摘要
本文扼要介绍我国十年来体内放射性药物的进展。诊断和治疗用体内放射性药物的发展很迅速,已有反应堆生产与加速器生产的系列医用放射性核素及放射性药物,尤其是^(99m)Tc标记的脑、心灌注显像剂、放射免疫显像剂等。本文还对今后的发展提出一些建议与展望。
The radiopharmaceutical chemistry is an important part in applied radio-chemistry. In this paper is given a review of in vivo radiopharmaceuticals in our country in recent years. It should be pointed out that in vivo radiopharmaceuticals including diagnostic and therapeutic have enjoyed rapid development. Recently, a series of reactor and cyclotron produced medical radionuclides and their radiopharmaceuticals, especially new 99mTc labelled brain perfusion imaging agents 99mTc-dl-HMPAO, 99mTc-ECD, myocardial perfusion imaging agents 99mTc-CPI and MIBI, radioimmunoimaging agents etc. have heen reported. Furthermore, R and D suggestions and future trends are discussed.
出处
《核化学与放射化学》
CAS
CSCD
北大核心
1989年第4期229-235,共7页
Journal of Nuclear and Radiochemistry
关键词
体内
放射性药物
现状
展望
In vivo radiopharmaceuticals, Diagnostic and therapeutic radiopharmaceuticals, Perfusion imaging agent, Radioimmunoimaging agent.
